RARA CRAFT DATABASE for FDA Medical Devices
510(k)K160709

FDA DEVICE FACTS

HALYARD* PURPLE NITRILE – XTRA* Powder-Free Exam Gloves

Halyard Health

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATESeptember 6, 2016PRODUCT CODELZC

Indications for use

HALYARD* PURPLE NITRILE - XTRA* Powder Free Exam Gloves tested for Use with Chemotherapy Drugs are powder-free patient examination gloves that are a disposable device intended for medical purposes worn on the examiner's hand or finger to prevent contamination between patient and examiner. This is an over the counter medical device. The HALYARD* PURPLE NITRILE - XTRA* Powder Pree Exam Gloves have been tested with the following Chemotherapy drugs showing no breakthrough up to 240 minutes. Carmustine showed breakthrough at 80.4 minutes I-I Break-through Tie.. (rial Break-through Time (mins) Break-through Time (mins) ChemoTherapy ChemoTherapy Drug (com.) ChemoTherapy Drug (cone)Drug (conc.) > 240 >240Doxorubicin HCIArsenic Trioxide, Paraplatin>240(1 mqimil (2 mglrmp( EllenceAzacitidine (Vidaza) Pemnetrexed P25 mab i Pertuzurnab (20 mu/mI) > 240 >240 '240 > 240 > 240 (25 mgfrn]) 2mo/nil) I- > 240Bendamustine Eribulin Mesylate (05MQ/l) > 240 > 240Bleomycin sulfate Etoposid Raltitrexed (0.5 mgl)>240(15 mg/ml_ (20 mgmn_) Bortezomib (Velcade) Fludarabine Retrovir Rituximab > 240 > 240 > 240 > 240 (1 mgfml) 125 uig/rrl) I- > 240 Fulvestrant (5o mq/mi) Busulfan > 240 > 240 > 240Fluorouracil (50 mg/mi) Carfilzomib (2 mg/ml) Carbopalin (10 mp/imi) Temsirclimus (25 mp/mi) > 240 > 240 enmcitabine ThioTEPA Topotean H1 (1 mIml) >240 '240 > 240110.4 IdarubicinCarmustine (3.3 mqlml) > 240 > 240 >240Cetuximab (Erbitux) ifosfamide Trastuzumab> 240 Cisplatin (1 mg/tell > 2;40_I Irnotecan f20 mg/trll Triclosan (1mg/mi) Trisenox

- 10.1giml > 240 '240 > 240 > 240 > 240I- > 240Cyclophosphamide (20 mp/lml) Mechlorethamine HCI (I mg/mit) I- > 240 >240Cytarabine HCI (100 mplm) Melphalan Vinblastine (1 mqimrl) > 240 > 240 jJ Cytovene 10a ml il)_ Methatrexate Vincrinstine Sulfate (1 mp/ml)> 240 (25 mg/i) Mitomycin (.5 mg/mlL ' 240Dacarbazine Vinorelbine (10 mSm0) >240 > 240il-9 rnghmi) Hel > 240 > 240Daunorublcin Mitoxantrone Zoledronic Acid > 240L5 m/ml) _2 rngrmi) (0.8 mgmll > 240Decitabine Oxaliplalin >240(2mg/mi) ((- fr, m) '40 L -I Pacitaxel > 240(6 1/I

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 2, 2026